The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Reassessing the Host Defense Peptide Landscape
Open accessAbstract
Current research has demonstrated that small cationic amphipathic peptides have strong potential not only as antimicrobials, but also as antibiofilm agents, immune modulators, and anti-inflammatories. Although traditionally termed antimicrobial peptides (AMPs) these additional roles have prompted a shift in terminology to use the broader term host defense peptides (HDPs) to capture the multi-functional nature of these molecules. In this review, we critically examined the role of AMPs and HDPs in infectious diseases and inflammation. It is generally accepted that HDPs are multi-faceted mediators of a wide range of biological processes, with individual activities dependent on their polypeptide sequence. In this context, we explore the concept of chemical space as it applies to HDPs and hypothesize that the various functions and activities of this class of molecule exist on independent but overlapping activity landscapes. Finally, we outline several emerging functions and roles of HDPs and highlight how an improved understanding of these processes can potentially be leveraged to more fully realize the therapeutic promise of HDPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“Formulating peptides with various delivery vectors such as liposomes (Yang et al., 2011; Allen and Cullis, 2013), nanoparticles (d’Angelo et al.”
BackgroundMolecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“Conceivably, this could involve some combination of peptide concentration gradients, Donnan potentials (created by the presence of polyanionic membrane-derived oligosaccharides in the bacterial periplasm) or the electrical potential gradient across the cytoplasmic membrane (Nikaido, 2003).”
BackgroundAntimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Self-citationMolecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
APD3: the antimicrobial peptide database as a tool for research and education
Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Self-citationAntimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 1×
“For instance, LL-37 has been shown to activate plasmacytoid dendritic cells by breaking tolerance to self-DNA (Lande et al., 2007), while it was demonstrated that LL-37 could also serve as an autoantigen for T-cells (Lande et al.”
BackgroundAgents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879 · cited 2×
“, Mg2+ and Ca2+) which in turn stabilize the outer membrane (Vaara, 1992).”
BackgroundElborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Self-citationMode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543 · cited 1×
“Compounding this issue is that chronic wounds are often colonized by bacteria growing in biofilms (James et al., 2008) that are intrinsically resistant to conventional antibiotics (Lopez et al.”
BackgroundSynthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Sequence and specificity of two antibacterial proteins involved in insect immunity
Steiner, H., Hultmark, D., Engström, Å., Bennich, H., & Boman, H. G. (1981) · Nature · doi:10.1038/292246a0 · Cited by 1,427
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,313
LeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., & Korfhagen, T. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.2.3303 · Cited by 1,273
The oral microbiome – an update for oral healthcare professionals
Kilian, M., Chapple, I. L. C., Hannig, M., Marsh, P. D., Meuric, V., Pedersen, A. M. L., Tonetti, M. S., Wade, W. G., & Zaura, E. (2016) · British Dental Journal · doi:10.1038/sj.bdj.2016.865 · Cited by 1,269 · cited 1×
“, 2005) and this may be reflective of the diverse oral microbiome composition amongst different individuals (Kilian et al., 2016).”
BackgroundPaneth cells, antimicrobial peptides and maintenance of intestinal homeostasis
Bevins, C. L., & Salzman, N. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2546 · Cited by 1,238
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Self-citationPotrykus, K., & Cashel, M. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162903 · Cited by 1,165
Enteric defensins are essential regulators of intestinal microbial ecology
Salzman, N. H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D., et al. (2010) · Nature Immunology · doi:10.1038/ni.1825 · Cited by 1,156
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,147
Gombart, A. F., Borregaard, N., & Koeffler, H. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3284com · Cited by 1,136
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Self-citationCystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
Wimley, W. C. (2010) · ACS Chemical Biology · doi:10.1021/cb1001558 · Cited by 1,001
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978 · cited 1×
“…than the native divalent cations) and upon membrane binding, the peptides competitively displace the divalent cations which subsequently interferes with lipid packing and leads to increased permeability of the outer membrane thereby mediating their so-called self-promoted uptake (Hancock, 2001).”
BackgroundSelf-citationThe immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Self-citationPark, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Cosio, M. G., Saetta, M., & Agusti, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804752 · Cited by 815
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Lopez, D., Vlamakis, H., & Kolter, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000398 · Cited by 797
Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., & Sahl, H.-G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 790
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
Antimicrobial Peptides: Mechanisms of Action and Resistance
Bechinger, B., & Gorr, S.-U. (2017) · Journal of Dental Research · doi:10.1177/0022034516679973 · Cited by 739
Wu, M., Maier, E., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9826299 · Cited by 736
Self-citationInteraction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
HIF-1α expression regulates the bactericidal capacity of phagocytes
Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A., Theodorakis, E. A., Gallo, R. L., Hurtado-Ziola, N., Nizet, V., & Johnson, R. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23865 · Cited by 702
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Self-citationMolecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666
Holgate, S. T., Wenzel, S., Postma, D. S., Weiss, S. T., Renz, H., & Sly, P. D. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.25 · Cited by 652
Psoriasis is associated with increased β-defensin genomic copy number
Hollox, E. J., Huffmeier, U., Zeeuwen, P. L. J. M., Palla, R., Lascorz, J., Rodijk-Olthuis, D., van de Kerkhof, P. C. M., Traupe, H., de Jongh, G., Heijer, M. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.48 · Cited by 627
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 598
Magainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551
Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H., Raventós, D. S., et al. (2010) · Science · doi:10.1126/science.1185723 · Cited by 550
Makrygiannakis, D., Hermansson, M., Ulfgren, A.-K., Nicholas, A. P., Zendman, A. J. W., Eklund, A., Grunewald, J., Skold, C. M., Klareskog, L., & Catrina, A. I. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075192 · Cited by 550
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Self-citationThe antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6621 · Cited by 539
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells
Préfontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemière, C., Martin, J. G., & Hamid, Q. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802387 · Cited by 538
Primary structures of three human neutrophil defensins.
Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112121 · Cited by 534
Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004152 · Cited by 521
Self-citationAntimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure
Lee, T.-H., N. Hall, K., & Aguilar, M.-I. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150703121700 · Cited by 512
Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study
Pütsep, K., Carlsson, G., Boman, H. G., & Andersson, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11201-3 · Cited by 499 · cited 2×
“Of note, all patients with morbus Kostmann experience severe periodontal disease, which is consistent with the suggestion that low LL-37 levels in the saliva could contribute to this disease phenotype (Pütsep et al., 2002).”
Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L. (2001) · Biochemistry · doi:10.1021/bi002656a · Cited by 491
Antimicrobial peptides and the skin immune defense system
Schauber, J., & Gallo, R. L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.027 · Cited by 477
Mechanism of antimicrobial action of indolicidin
Subbalakshmi, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00008-1 · Cited by 474
de la Fuente-Núñez, C., Korolik, V., Bains, M., Nguyen, U., Breidenstein, E. B. M., Horsman, S., Lewenza, S., Burrows, L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-12 · Cited by 459
Self-citationRelationship of Membrane Curvature to the Formation of Pores by Magainin 2
Matsuzaki, K., Sugishita, K.-I., Ishibe, N., Ueha, M., Nakata, S., Miyajima, K., & Epand, R. M. (1998) · Biochemistry · doi:10.1021/bi980539y · Cited by 452
Murein (peptidoglycan) structure, architecture and biosynthesis in Escherichia coli
Vollmer, W., & Bertsche, U. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.06.007 · Cited by 451
Biofilms and Inflammation in Chronic Wounds
Zhao, G., Usui, M. L., Lippman, S. I., James, G. A., Stewart, P. S., Fleckman, P., & Olerud, J. E. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0381 · Cited by 448
The antibiotic resistance crisis, with a focus on the United States
Martens, E., & Demain, A. L. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.30 · Cited by 445
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Self-citationOptimization of the antimicrobial activity of magainin peptides by modification of charge
Dathe, M., Nikolenko, H., Meyer, J., Beyermann, M., & Bienert, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02648-5 · Cited by 432
Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization
Fan, D., Coughlin, L. A., Neubauer, M. M., Kim, J., Kim, M. S., Zhan, X., Simms-Waldrip, T. R., Xie, Y., Hooper, L. V., & Koh, A. Y. (2015) · Nature Medicine · doi:10.1038/nm.3871 · Cited by 426 · cited 1×
“The commensal bacterium Bacteroides thetaiotamicron has been shown to activate HIF-1α and promote cathelicidin production in the gut of mice previously exposed to antibiotics which in turn prevented invasive colonization by Candida albicans (Fan et al., 2015).”
BackgroundYin, L. M., Edwards, M. A., Li, J., Yip, C. M., & Deber, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303602 · Cited by 423
Antimicrobial peptides and wound healing: biological and therapeutic considerations
Mangoni, M. L., McDermott, A. M., & Zasloff, M. (2016) · Experimental Dermatology · doi:10.1111/exd.12929 · Cited by 415
Harder, J., Meyer-Hoffert, U., Teran, L. M., Schwichtenberg, L., Bartels, J., Maune, S., & Schröder, J.-M. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.6.4023 · Cited by 414
An anti-infective peptide that selectively modulates the innate immune response
Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1288 · Cited by 403
Self-citationAntimicrobial peptides and their interaction with biofilms of medically relevant bacteria
Batoni, G., Maisetta, G., & Esin, S. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.013 · Cited by 401
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
Schauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides
Lázár, V., Martins, A., Spohn, R., Daruka, L., Grézal, G., Fekete, G., Számel, M., Jangir, P. K., Kintses, B., Csörgő, B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0164-0 · Cited by 375
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Self-citationBacterial strategies of resistance to antimicrobial peptides
Joo, H.-S., Fu, C.-I., & Otto, M. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0292 · Cited by 360
Cherkasov, A., Hilpert, K., Jenssen, H., Fjell, C. D., Waldbrook, M., Mullaly, S. C., Volkmer, R., & Hancock, R. E. W. (2009) · ACS Chemical Biology · doi:10.1021/cb800240j · Cited by 357
Self-citationAnionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Discovering and improving novel peptide therapeutics
MCGREGOR, D. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.002 · Cited by 331
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Ostaff, M. J., Stange, E. F., & Wehkamp, J. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201773 · Cited by 329
de la Fuente-Núñez, C., Reffuveille, F., Mansour, S. C., Reckseidler-Zenteno, S. L., Hernández, D., Brackman, G., Coenye, T., & Hancock, R. E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.002 · Cited by 323
Self-citationDistinct antimicrobial peptide expression determines host species-specific bacterial associations
Franzenburg, S., Walter, J., Künzel, S., Wang, J., Baines, J. F., Bosch, T. C. G., & Fraune, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304960110 · Cited by 312
Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment
Coussens, A. K., Wilkinson, R. J., Hanifa, Y., Nikolayevskyy, V., Elkington, P. T., Islam, K., Timms, P. M., Venton, T. R., Bothamley, G. H., Packe, G. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200072109 · Cited by 310
A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Self-citationPeptide design for antimicrobial and immunomodulatory applications
Haney, E. F., & Hancock, R. E. W. (2013) · Peptide Science · doi:10.1002/bip.22250 · Cited by 291
Self-citationAntimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Rozek, T., Wegener, K. L., Bowie, J. H., Olver, I. N., Carver, J. A., Wallace, J. C., & Tyler, M. J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01536.x · Cited by 288
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
Wang, S., & Wang, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.07.003 · Cited by 285
Properties and mechanisms of action of naturally occurring antifungal peptides
van der Weerden, N. L., Bleackley, M. R., & Anderson, M. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1260-1 · Cited by 271
Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action
Scocchi, M., Tossi, A., & Gennaro, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0721-7 · Cited by 267
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides
Bader, M. W., Navarre, W. W., Shiau, W., Nikaido, H., Frye, J. G., McClelland, M., Fang, F. C., & Miller, S. I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03675.x · Cited by 260
Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model
Torrent, M., Andreu, D., Nogués, V. M., & Boix, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016968 · Cited by 260
Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci
Sass, V., Schneider, T., Wilmes, M., Körner, C., Tossi, A., Novikova, N., Shamova, O., & Sahl, H.-G. (2010) · Infection and Immunity · doi:10.1128/iai.00688-09 · Cited by 254
Diversity, evolution and medical applications of insect antimicrobial peptides
Mylonakis, E., Podsiadlowski, L., Muhammed, M., & Vilcinskas, A. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0290 · Cited by 254
Intestinal antimicrobial peptides during homeostasis, infection, and disease
Muniz, L. R., Knosp, C., & Yeretssian, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00310 · Cited by 252
Administration of oral vitamin D induces cathelicidin production in atopic individuals
Hata, T. R., Kotol, P., Jackson, M., Nguyen, M., Paik, A., Udall, D., Kanada, K., Yamasaki, K., Alexandrescu, D., & Gallo, R. L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.08.020 · Cited by 248
A linguistic model for the rational design of antimicrobial peptides
Loose, C., Jensen, K., Rigoutsos, I., & Stephanopoulos, G. (2006) · Nature · doi:10.1038/nature05233 · Cited by 247
Delivery systems for antimicrobial peptides
Nordström, R., & Malmsten, M. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.01.005 · Cited by 246
Pirtskhalava, M., Gabrielian, A., Cruz, P., Griggs, H. L., Squires, R. B., Hurt, D. E., Grigolava, M., Chubinidze, M., Gogoladze, G., Vishnepolsky, B., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1174 · Cited by 244
Antimicrobial peptides in the pathogenesis of psoriasis
MORIZANE, S., & GALLO, R. L. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01483.x · Cited by 237
Sandgren, S., Wittrup, A., Cheng, F., Jönsson, M., Eklund, E., Busch, S., & Belting, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311440200 · Cited by 236
DRAMP: a comprehensive data repository of antimicrobial peptides
Fan, L., Sun, J., Zhou, M., Zhou, J., Lao, X., Zheng, H., & Xu, H. (2016) · Scientific Reports · doi:10.1038/srep24482 · Cited by 232
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils.
Selsted, M. E., Brown, D. M., DeLange, R. J., Harwig, S. S., & Lehrer, R. I. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89110-4 · Cited by 231
Dosler, S., & Karaaslan, E. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.021 · Cited by 226
Friedrich, C. L., Rozek, A., Patrzykat, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009691200 · Cited by 225
Self-citationAntibiofilm Peptides: Potential as Broad-Spectrum Agents
Pletzer, D., & Hancock, R. E. W. (2016) · Journal of Bacteriology · doi:10.1128/jb.00017-16 · Cited by 220
Self-citationSynthetic antibiofilm peptides
de la Fuente-Núñez, C., Cardoso, M. H., de Souza Cândido, E., Franco, O. L., & Hancock, R. E. W. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.015 · Cited by 214
Self-citationOn the Mechanism of Pore Formation by Melittin
van den Bogaart, G., Guzmán, J. V., Mika, J. T., & Poolman, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805171200 · Cited by 213
Pletzer, D., Mansour, S. C., & Hancock, R. E. W. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007084 · Cited by 211
Self-citationSalivary Antimicrobial Peptide Expression and Dental Caries Experience in Children
Tao, R., Jurevic, R. J., Coulton, K. K., Tsutsui, M. T., Roberts, M. C., Kimball, J. R., Wells, N., Berndt, J., & Dale, B. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3883-3888.2005 · Cited by 210
Mansour, S. C., de la Fuente‐Núñez, C., & Hancock, R. E. W. (2015) · Journal of Peptide Science · doi:10.1002/psc.2708 · Cited by 208
Self-citationNijnik, A., & Hancock, R. E. W. (2009) · Emerging Health Threats Journal · doi:10.3134/ehtj.09.001 · Cited by 204
Self-citationHollmann, A., Martínez, M., Noguera, M. E., Augusto, M. T., Disalvo, A., Santos, N. C., Semorile, L., & Maffía, P. C. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.02.003 · Cited by 197
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria
Li, W., Tailhades, J., O’Brien-Simpson, N. M., Separovic, F., Otvos, L., Hossain, M. A., & Wade, J. D. (2014) · Amino Acids · doi:10.1007/s00726-014-1820-1 · Cited by 192
Grönberg, A., Mahlapuu, M., Ståhle, M., Whately‐Smith, C., & Rollman, O. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12211 · Cited by 191
An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome
Florin, T., Maracci, C., Graf, M., Karki, P., Klepacki, D., Berninghausen, O., Beckmann, R., Vázquez-Laslop, N., Wilson, D. N., Rodnina, M. V., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3439 · Cited by 190
Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides
Scott, M. G., Yan, H., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/.67.4.2005-2009.1999 · Cited by 189
Self-citationLai, Y., Villaruz, A. E., Li, M., Cha, D. J., Sturdevant, D. E., & Otto, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05540.x · Cited by 183
Sequence Requirements and an Optimization Strategy for Short Antimicrobial Peptides
Hilpert, K., Elliott, M. R., Volkmer-Engert, R., Henklein, P., Donini, O., Zhou, Q., Winkler, D. F. H., & Hancock, R. E. W. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.08.014 · Cited by 183
Self-citationInteraction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria
Scott, M. G., Gold, M. R., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6445-6453.1999 · Cited by 181
Self-citationAntimicrobial Peptides: the Achilles’ Heel of Antibiotic Resistance?
Lewies, A., Du Plessis, L. H., & Wentzel, J. F. (2019) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9465-0 · Cited by 180
Antibacterial peptides and proteins with multiple cellular targets
Otvos, L. J. (2005) · Journal of Peptide Science · doi:10.1002/psc.698 · Cited by 178
Fernández, L., Jenssen, H., Bains, M., Wiegand, I., Gooderham, W. J., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01530-12 · Cited by 178
Self-citationRaftery, T., Martineau, A. R., Greiller, C. L., Ghosh, S., McNamara, D., Bennett, K., Meddings, J., & O’Sullivan, M. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615572176 · Cited by 174
Nagarajan, D., Nagarajan, T., Roy, N., Kulkarni, O., Ravichandran, S., Mishra, M., Chakravortty, D., & Chandra, N. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.805499 · Cited by 174
Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology
Guo, L., McLean, J. S., Yang, Y., Eckert, R., Kaplan, C. W., Kyme, P., Sheikh, O., Varnum, B., Lux, R., Shi, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506207112 · Cited by 172
The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
Kuroda, K., Okumura, K., Isogai, H., & Isogai, E. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00144 · Cited by 169
Yoshida, M., Hinkley, T., Tsuda, S., Abul-Haija, Y. M., McBurney, R. T., Kulikov, V., Mathieson, J. S., Galiñanes Reyes, S., Castro, M. D., & Cronin, L. (2018) · Chem · doi:10.1016/j.chempr.2018.01.005 · Cited by 169
Alfei, S., & Schito, A. M. (2020) · Polymers · doi:10.3390/polym12051195 · Cited by 168
d’Angelo, I., Casciaro, B., Miro, A., Quaglia, F., Mangoni, M. L., & Ungaro, F. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.027 · Cited by 166
Structural Studies of a Peptide with Immune Modulating and Direct Antimicrobial Activity
Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R. P., Elliott, M., Hilpert, K., Cheng, J. T. J., Hancock, R. E. W., & Straus, S. K. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.007 · Cited by 166
Self-citationDefensins and other antimicrobial peptides in inflammatory bowel disease
Wehkamp, J., Schmid, M., & Stange, E. F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328136c580 · Cited by 165
Intracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes
Mookherjee, N., Lippert, D. N. D., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., Pistolic, J., Gardy, J., Miri, P., Naseer, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802586 · Cited by 163
Self-citationBaAMPs: the database of biofilm-active antimicrobial peptides
Di Luca, M., Maccari, G., Maisetta, G., & Batoni, G. (2015) · Biofouling · doi:10.1080/08927014.2015.1021340 · Cited by 163
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells
von Haussen, J., Koczulla, R., Shaykhiev, R., Herr, C., Pinkenburg, O., Reimer, D., Wiewrodt, R., Biesterfeld, S., Aigner, A., Czubayko, F., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.07.014 · Cited by 161
Tucker, A. T., Leonard, S. P., DuBois, C. D., Knauf, G. A., Cunningham, A. L., Wilke, C. O., Trent, M. S., & Davies, B. W. (2018) · Cell · doi:10.1016/j.cell.2017.12.009 · Cited by 158
Human defensins as cancer biomarkers and antitumour molecules
Droin, N. M., Hendra, J.-B., Ducoroy, P., & Solary, É. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.01.002 · Cited by 156
Lee, E. Y., Lee, M. W., Fulan, B. M., Ferguson, A. L., & Wong, G. C. L. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0153 · Cited by 156
Wu, W. K. K., Wang, G., Coffelt, S. B., Betancourt, A. M., Lee, C. W., Fan, D., Wu, K., Yu, J. Q., Sung, J. J. �., & Cho, C. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25489 · Cited by 153
Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
Findlay, E. G., Currie, S. M., & Davidson, D. J. (2013) · BioDrugs · doi:10.1007/s40259-013-0039-0 · Cited by 151
Wu, X., Li, Z., Li, X., Tian, Y., Fan, Y., Yu, C., Zhou, B., Liu, Y., Xiang, R., & Yang, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s107195 · Cited by 150
Lau, Y. E., Rozek, A., Scott, M. G., Goosney, D. L., Davidson, D. J., & Hancock, R. E. W. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.583-591.2005 · Cited by 145
Self-citationBlondelle, S. E., & Lohner, K. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<74::aid-bip70>3.0.co;2-s · Cited by 139
Heilborn, J. D., Nilsson, M. F., Chamorro, C. I., Sandstedt, B., Borregaard, N., Tham, E., Sørensen, O. E., Weber, G., & Ståhle, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20795 · Cited by 135
Charge distribution and imperfect amphipathicity affect pore formation by antimicrobial peptides
Mihajlovic, M., & Lazaridis, T. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.016 · Cited by 134
Rivas-Santiago, B. T., Rivas-Santiago, C., Castañeda‐Delgado, J. E., León‐Contreras, J. C., Hancock, R. E. W., & Hernández‐Pando, R. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.015 · Cited by 130
Self-citationGrossmann, R. E., Zughaier, S. M., Liu, S., Lyles, R. H., & Tangpricha, V. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.82 · Cited by 130
Marquette, A., & Bechinger, B. (2018) · Biomolecules · doi:10.3390/biom8020018 · Cited by 129
Åberg, A., Shingler, V., & Balsalobre, C. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05191.x · Cited by 128
Arias, M., Piga, K. B., Hyndman, M. E., & Vogel, H. J. (2018) · Biomolecules · doi:10.3390/biom8020019 · Cited by 128
Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37
Lin, Q., Deslouches, B., Montelaro, R. C., & Di, Y. P. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.04.019 · Cited by 127
Rivas-Santiago, B. T., Castañeda‐Delgado, J. E., Rivas-Santiago, C., Waldbrook, M., Gonzalez-Curiel, I. E., León‐Contreras, J. C., Enciso‐Moreno, J. A., del Villar, V., Mendez-Ramos, J., Hancock, R. E. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059119 · Cited by 124
Self-citationHow Many Antimicrobial Peptide Molecules Kill a Bacterium? The Case of PMAP-23
Roversi, D., Luca, V., Aureli, S., Park, Y., Mangoni, M. L., & Stella, L. (2014) · ACS Chemical Biology · doi:10.1021/cb500426r · Cited by 124
Visualizing Attack of Escherichia coli by the Antimicrobial Peptide Human Defensin 5
Chileveru, H. R., Lim, S. A., Chairatana, P., Wommack, A. J., Chiang, I.-L., & Nolan, E. M. (2015) · Biochemistry · doi:10.1021/bi501483q · Cited by 124
Allergic Airway Inflammation Inhibits Pulmonary Antibacterial Host Defense
Beißwenger, C., Kändler, K., Hess, C., Garn, H., Felgentreff, K., Wegmann, M., Renz, H. E., Vogelmeier, C. F., & Bals, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1833 · Cited by 122
Stringent Response Regulation of Biofilm Formation in Vibrio cholerae
He, H., Cooper, J. N., Mishra, A., & Raskin, D. M. (2012) · Journal of Bacteriology · doi:10.1128/jb.00014-12 · Cited by 120
Kovach, M. A., Ballinger, M. N., Newstead, M. W., Zeng, X., Bhan, U., Yu, F. X., Moore, B. B., Gallo, R. L., & Standiford, T. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103196 · Cited by 119
Strategies in Translating the Therapeutic Potentials of Host Defense Peptides
Ting, D. S. J., Beuerman, R. W., Dua, H. S., Lakshminarayanan, R., & Mohammed, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00983 · Cited by 119
Antimicrobial Peptides and Innate Lung Defenses
Hiemstra, P. S., Amatngalim, G. D., van der Does, A. M., & Taube, C. (2015) · CHEST Journal · doi:10.1378/chest.15-1353 · Cited by 117
Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia
Loutet, S. A., & Valvano, M. A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00159 · Cited by 116
Coffelt, S. B., Waterman, R. S., Flórez, L., zu Bentrup, K. H., Zwezdaryk, K. J., Tomchuck, S. L., LaMarca, H. L., Danka, E. S., Morris, C. A., & Scandurro, A. B. (2007) · International Journal of Cancer · doi:10.1002/ijc.23186 · Cited by 116
Computer-aided Discovery of Peptides that Specifically Attack Bacterial Biofilms
Haney, E. F., Brito‐Sánchez, Y., Trimble, M. J., Mansour, S., Cherkasov, A. R., & Hancock, R. E. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-19669-4 · Cited by 116
Self-citationSahariah, P., Sørensen, K. K., Hjálmarsdóttir, M. Á., Sigurjónsson, Ó. E., Jensen, K. J., Másson, M., & Thygesen, M. B. (2015) · Chemical Communications · doi:10.1039/c5cc04010h · Cited by 115
Cancer-Specific Loss of β-Defensin 1 in Renal and Prostatic Carcinomas
Donald, C. D., Sun, C. Q., Lim, S. D., Macoska, J. A., Cohen, C., Amin, M. B., Young, A. N., Ganz, T., Marshall, F. F., & Petros, J. A. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000063929.61760.f6 · Cited by 115
Oral Antimicrobial Peptides and Biological Control of Caries
Dale, B. A., Tao, R., Kimball, J. R., & Jurevic, R. J. (2006) · BMC Oral Health · doi:10.1186/1472-6831-6-s1-s13 · Cited by 115
Immunomodulators as adjuvants for vaccines and antimicrobial therapy
Nicholls, E. F., Madera, L., & Hancock, R. E. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05787.x · Cited by 111
Self-citationThe proteome targets of intracellular targeting antimicrobial peptides
SHAH, P. M., Hsiao, F. S., Ho, Y.-H., & Chen, C. (2015) · PROTEOMICS · doi:10.1002/pmic.201500380 · Cited by 111
Kilsgård, O., Andersson, P., Malmsten, M., Nordin, S. L., Linge, H. M., Eliasson, M., Sörenson, E., Erjefalt, J. S., Bylund, J., Olin, A. I., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0500oc · Cited by 107
Haney, E. F., Mansour, S., Hilchie, A. L., de la Fuente‐Núñez, C., & Hancock, R. E. W. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.015 · Cited by 106
Self-citationMolecular mechanisms of LL-37-induced receptor activation: An overview
Verjans, E., Zels, S., Luyten, W. H. M. L., Landuyt, B., & Schoofs, L. (2016) · Peptides · doi:10.1016/j.peptides.2016.09.002 · Cited by 105
Antimicrobial Peptides and Colitis
Ho, S., Pothoulakis, C., & Koon, H. W. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128130108 · Cited by 104
Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization
Maccari, G., Luca, M. D., Nifosì, R., Cardarelli, F., Signore, G., Boccardi, C., & Bifone, A. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003212 · Cited by 104
Cheng, J., Hale, J. D. F., Elliot, M., Hancock, R. E. W., & Straus, S. K. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.012 · Cited by 102
Self-citationBullard, R. S., Gibson, W., Bose, S. K., Belgrave, J. K., Eaddy, A. C., Wright, C. J., Hazen‐Martin, D. J., Lage, J. M., Keane, T. E., Ganz, T., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.11.026 · Cited by 100
Cheng, J., Hale, J. D. F., Elliott, M. R., Hancock, R. E. W., & Straus, S. K. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.11.025 · Cited by 98
Self-citationHuman antimicrobial peptides and cancer
Jin, G., & Weinberg, A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.04.006 · Cited by 96
Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides
Porto, W. F., Fensterseifer, I. C. M., Ribeiro, S. M., & Franco, O. L. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.06.011 · Cited by 96
Luo, Y., McLean, D. T. F., Linden, G. J., McAuley, D. F., McMullan, R., & Lundy, F. T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00544 · Cited by 92
Mader, J. S., Mookherjee, N., Hancock, R. E. W., & Bleackley, R. C. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0274 · Cited by 89
Self-citationMansour, S., Pletzer, D., de la Fuente‐Núñez, C., Kim, P., Cheung, G. Y. C., Joo, H., Otto, M. J., & Hancock, R. E. W. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.015 · Cited by 89
Self-citationHost Cell Interactions Are a Significant Barrier to the Clinical Utility of Peptide Antibiotics
Starr, C. G., He, J., & Wimley, W. C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00843 · Cited by 89
Anticancer activities of bovine and human lactoferricin-derived peptides
Arias, M., Hilchie, A. L., Haney, E. F., Bolscher, J. G. M., Hyndman, M. E., Hancock, R. E. W., & Vogel, H. J. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0175 · Cited by 87
Self-citationRescue of Dysfunctional Autophagy Attenuates Hyperinflammatory Responses from Cystic Fibrosis Cells
Mayer, M. L., Blohmke, C. J., Falsafi, R., Fjell, C. D., Madera, L., Turvey, S. E., & Hancock, R. E. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201404 · Cited by 86
Self-citationBrunetti, J., Falciani, C., Roscia, G., Pollini, S., Bindi, S., Scali, S., Cossío, U., Gómez‐Vallejo, V., Quercini, L., Ibba, E., et al. (2016) · Scientific Reports · doi:10.1038/srep26077 · Cited by 86
Salivary concentration of the antimicrobial peptide LL-37 in children
Davidopoulou, S., Diza, E., Menexes, G. C., & Kalfas, S. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.01.008 · Cited by 85
Majchrzykiewicz-Koehorst, J. A., Kuipers, O. P., & Bijlsma, J. J. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00769-09 · Cited by 85
The role of antimicrobial peptides in chronic inflammatory skin diseases
Marcinkiewicz, M., & Majewski, S. T. (2016) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2015.48066 · Cited by 84
Cited by
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
Self-citationMechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
Raheem, N., & Straus, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02866 · Cited by 369
Self-citation
Metadata
- Authors
- Haney, E. F., Straus, S. K., & Hancock, R. E. W.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2019-02-04
- Volume
- 7
- Pages
- 43-43
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W2914213905
- Cited by
- 359
- References
- 262
- FWCI
- 34.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.